ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹97 Cr | ₹106 Cr | ₹78 Cr | ₹60 Cr | ₹68 Cr |
What is the latest Total Current Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹97 Cr |
Mar2024 | ₹106 Cr |
Mar2023 | ₹78 Cr |
Mar2022 | ₹60 Cr |
Mar2021 | ₹68 Cr |
How is Total Current Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹97 Cr | -9.03 | |
Mar2024 | ₹106 Cr | 37.12 | |
Mar2023 | ₹78 Cr | 28.37 | |
Mar2022 | ₹60 Cr | -10.56 | |
Mar2021 | ₹68 Cr | - |
Compare Total Current Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ADVANCED ENZYME TECHNOLOGIES | ₹3,606.0 Cr | -2.5% | 0.5% | -13.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ADVANCED ENZYME TECHNOLOGIES | -2.5% |
0.5% |
-13.9% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses